z-logo
open-access-imgOpen Access
Reducing False-Negative Tests in Urinary Drugs-of-Abuse Screening
Author(s) -
Francesca Luceri,
Flavio Godi,
Gianni Messeri
Publication year - 1997
Publication title -
journal of analytical toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.161
H-Index - 76
eISSN - 1945-2403
pISSN - 0146-4760
DOI - 10.1093/jat/21.3.244
Subject(s) - drugs of abuse , urinary system , substance abuse detection , medicine , substance abuse , drug , pharmacology , psychiatry
reduction of the immunoassay signal, potentially yielding falsely negative results. The dilution of the urine sample, either by ingestion of considerable volume of liquids or by assumption of diuretic substances, is another common method of deception to push the analyte concentration below the adopted cutoff. In this context, the urinary creatinine concentration can be used to verify the extent of the urine dilution. An extended study on the importance of urinary creatinine measurement for detection of presumably false-negative samples tested for abused drugs was reported by Lafolie et al. (6). In that paper, the authors suggest that a creatinine value < 4.0 mmol/L can be used as a cutoff in discriminating between physiologically and nonphysiologically diluted samples. Moreover, they propose to simply concentrate the urine to test the authenticity of the sample. Following this approach, 100 samples, all of which were negative for all the drugs by the initial immunoassay (Cloned Enzyme Donor Immuno Assay [CEDIA] Boehringer Mannheim, Tutzing, Germany) and of which displayed a "suspect" urinary creatinine value (< 4 mmol/L), were concentrated at 37~ under a stream of nitrogen. The samples were evaporated until the creatinine concentration approached a normal value (3- to 6-fold concentration). Of these samples, 27 were positive when retested by the CEDIA immunoassay, and all the positive results were confirmed by gas chromatography-mass spectrometry (Table I). We developed this procedure following a request of our Addiction Treatment Centers (Servizi Tossicodipendenze, SERT), which is equally interested in lowering the number of falsely positive and falsely negative results. As a matter of fact, both of these errors are detrimental to the recovery programs of drug addicts. At the moment, whereas samples positive after the irnmunoassay undergo confirmation by chromatographic techniques, the negative ones are not further investigated. The procedure we described is very simple, rapid, and effective in any case of adulteration that is due to dilution and can reduce falsely negative results in urine testing for abused drugs.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom